Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study

被引:7
|
作者
Kim, Mihui [1 ]
Yang, Yong Sook [1 ]
Ko, Young-Guk [2 ]
Choi, Mona [3 ]
机构
[1] Yonsei Univ, Coll Nursing, Brain Korea 21 4 Project, Seoul 03722, South Korea
[2] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 03722, South Korea
[3] Yonsei Univ, Mo Im Kim Nursing Res Inst, Coll Nursing, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
diabetes mellitus; exercise; major adverse cardiovascular event; major adverse limb event; peripheral artery disease; CHRONIC KIDNEY-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; ASSOCIATION; EPIDEMIOLOGY; MECHANISMS; EXERCISE; SYSTEM;
D O I
10.3390/jcm11092547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods: We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan-Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses. Results: Kaplan-Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant. Conclusion: Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Cost Analysis of Initial Treatment With Endovascular Revascularization, Open Surgery, or Primary Major Amputation in Patients With Peripheral Artery Disease
    Tang, Linda
    Paravastu, Sharath C. V.
    Thomas, Shannon D.
    Tan, Elaine
    Farmer, Eric
    Varcoe, Ramon L.
    JOURNAL OF ENDOVASCULAR THERAPY, 2018, 25 (04) : 504 - 511
  • [42] Major Adverse Limb Events Among Patients with Premature Peripheral Artery Disease Compared with Those at the Common Age Undergoing Revascularization in the Vascular Quality Initiative
    Kim, Tanner I.
    Loh, Sarah
    DeWan, Andrew
    Murray, Michael
    Mojibian, Hamid
    Mani, Arya
    Mena-Hurtado, Carlos
    Chaar, Cassius Iyad Ochoa
    ANNALS OF VASCULAR SURGERY, 2022, 87 : 188 - 197
  • [43] Impaired Peripheral Microvascular Function and Risk of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
    Young, An
    Sullivan, Samaah
    Lima, Bruno B.
    Liu, Chang
    Hammadah, Muhammad
    Ko, Yi-An
    Shah, Amit J.
    Kim, Jeong Hwan
    Moazzami, Kasra
    Alkhalaf, Mhmtjamil
    Bremner, J. Douglas
    Raggi, Paolo
    Quyyumi, Arshed A.
    Vaccarino, Viola
    CIRCULATION, 2019, 140
  • [44] Prediction of Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease Using Circulating Immunomodulatory Proteins
    Li, Ben
    Shaikh, Farah
    Younes, Houssam
    Abuhalimeh, Batool
    Chin, Jason
    Rasheed, Khurram
    Zamzam, Abdelrahman
    Abdin, Rawand
    Qadura, Mohammad
    BIOMEDICINES, 2024, 12 (12)
  • [45] Impaired Peripheral Microvascular Function and Risk of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
    Young, An
    Garcia, Mariana
    Sullivan, Samaah M.
    Liu, Chang
    Moazzami, Kasra
    Ko, Yi-An
    Shah, Amit J.
    Kim, Jeong Hwan
    Pearce, Brad
    Uphoff, Irina
    Bremner, J. Douglas
    Raggi, Paolo
    Quyyumi, Arshed
    Vaccarino, Viola
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (05) : 1801 - 1809
  • [46] Correction to: Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease
    Ariel Berger
    Alex Simpson
    Nicholas J. Leeper
    Brian Murphy
    Beth Nordstrom
    Windsor Ting
    Qi Zhao
    Jeffrey Berger
    Advances in Therapy, 2020, 37 : 974 - 974
  • [47] Increased radial artery tonometry is associated with an increased rate of major adverse cardiac events in patients with peripheral artery disease
    Ramirez, Joel L.
    Spaulding, Kimberly A.
    Zahner, Greg J.
    Khetani, Sukaynah A.
    Schaller, Melinda S.
    Gasper, Warren J.
    Hills, Nancy K.
    Grenon, S. Marlene
    VASCULAR MEDICINE, 2018, 23 (03) : 311 - 312
  • [48] Management of Patients After Endovascular Interventions for Peripheral Artery Disease
    Sobieszczyk, Piotr
    Eisenhauer, Andrew
    CIRCULATION, 2013, 128 (07) : 749 - 757
  • [49] Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease
    Golledge, Jonathan
    Velu, Ramesh
    Quigley, Frank
    Jenkins, Jason
    Singh, Tejas P.
    ANNALS OF VASCULAR SURGERY, 2022, 78 : 310 - 320
  • [50] Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease
    Altin, S. Elissa
    Castro-Dominguez, Yulanka S.
    Kennedy, Kevin F.
    Orion, Kristine C.
    Lanksy, Alexandra J.
    Abbott, J. Dawn
    Aronow, Herbert D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (24) : 2911 - 2918